R&D in Healthcare
Vibrant science across the globe
Patients are at the center of all our research and development efforts. We are committed to innovation in science that will ultimately make a meaningful difference in people’s lives all over the world. Ever since Merck KGaA, Darmstadt, Germany, was founded 350 years ago, we have gained unmatched experience in the discovery, development and manufacturing of medicines.
On top of leveraging our experience and expertise, we also believe that a healthier future deserves a sizable investment. In 2018 our Healthcare business devoted roughly 20% of total sales to R&D activities aimed at discovering and developing new therapies. All of these are integrated in a global organization with four strategically located and highly connected hubs on three continents: Darmstadt, Boston, Beijing and Tokyo.
Latest R&D NewsView All News
Combined efforts aim to develop an artificial intelligence (AI) technology that detects both schistosomiasis and soil-transmitted helminthiasis
Merck KGaA, Darmstadt, Germany and Pfizer Inc. today announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BAVENCIO® (avelumab).
Merck KGaA, Darmstadt, Germany today announced the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug application for M5049 for the treatment of patients with Covid-19 pneumonia.
Diversity is a source of strength. As centers of excellence, our four global R&D hubs allow the 3,000 professionals of our Healthcare research and development team to leverage different cultures, regional knowledge and broad perspectives.
Head of Research and Development
Work With Us
Join our R&D team
Are you curious to see how you can contribute to a healthier future? Join our team of scientists and development professionals! You can find all open positions within our Healthcare business in the Careers section.View recent job offers